VanEck Biotech ETF
BBH
BBH
103 hedge funds and large institutions have $121M invested in VanEck Biotech ETF in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 30 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
37% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 30
Holders
103
Holding in Top 10
–
Calls
$239K
Puts
$211K
Top Buyers
| 1 | +$4.06M | |
| 2 | +$1.77M | |
| 3 | +$1.67M | |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$1.48M |
| 5 |
LJAC
L.J. Altfest & Co
New York
|
+$788K |
Top Sellers
| 1 | -$4.42M | |
| 2 | -$3.36M | |
| 3 | -$1.75M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.53M |
| 5 |
LPL Financial
San Diego,
California
|
-$1.41M |